Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
Gallbladder cancer (GBC) is the most common biliary tract tumor with a poor prognosis. Isorhamnetin is a flavonoid compound extracted from Hippophae rhamnoides L. and has several pharmacological effects including anti-inflammatory and anti-cancer properties. We treated GBC-SD and NOZ of GBC cell lin...
Main Authors: | Tianyu Zhai, Xiaoyu Zhang, Zhenyu Hei, Longyang Jin, Chao Han, Audrey Tsznam Ko, Xiaofeng Yu, Jiandong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.628621/full |
Similar Items
-
Isorhamnetin: A review of pharmacological effects
by: Gang Gong, et al.
Published: (2020-08-01) -
Antiplatelet Activity of Isorhamnetin via Mitochondrial Regulation
by: Lyanne Rodríguez, et al.
Published: (2021-04-01) -
A New Isorhamnetin Glycoside and Other Phenolic Compounds from Callianthemum taipaicum
by: Yu-Juan Zhang, et al.
Published: (2012-04-01) -
Isorhamnetin Ameliorates Dry Eye Disease via CFTR Activation in Mice
by: Ho K. Lee, et al.
Published: (2021-04-01) -
Effects of Isorhamnetin on Adipocyte Mitochondrial Biogenesis and AMPK Activation
by: Mak-Soon Lee, et al.
Published: (2018-07-01)